Literature DB >> 27677541

Immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma: how they work and when to use them.

Kerry J Savage1,2, Christian Steidl1,3.   

Abstract

Entities:  

Keywords:  Hodgkin lymphoma; Lymphoma; biomarker; checkpoint inhibition; clinical trial; microenvironment

Mesh：

Substances：

Year:  2016        PMID： 27677541     DOI： 10.1080/17474086.2016.1242404

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN： 1747-4094            Impact factor:   2.929


× No keyword cloud information.
  3 in total

1.  Flow cytometry for assessment of the tumor microenvironment in pediatric Hodgkin lymphoma.

Authors:  Meret Henry; Steven Buck; Süreyya Savaşan
Journal:  Pediatr Blood Cancer       Date:  2018-07-15       Impact factor: 3.167

2.  The promise of Immuno-oncology: implications for defining the value of cancer treatment.

Authors:  Howard L Kaufman; Michael B Atkins; Prasun Subedi; James Wu; James Chambers; T Joseph Mattingly; Jonathan D Campbell; Jeff Allen; Andrea E Ferris; Richard L Schilsky; Daniel Danielson; J Leonard Lichtenfeld; Linda House; Wendy K D Selig
Journal:  J Immunother Cancer       Date:  2019-05-17       Impact factor: 13.751

Review 3.  Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma.

Authors:  Adam Yuh Lin; Joseph Michael Schnitter; Leo I Gordon
Journal:  Immunotargets Ther       Date:  2022-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.